Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > BB target raised to $0.90

<< Previous

Bullboard Posts

Next >>

Comment by Lawyerupon Dec 20, 2024 4:21pm

58 Views

Post# 36372919

RE:BB target raised to $0.90

I think the previous target was 80 cents. Really undervalued at these levels. I have been an active buyer the past few months so good to see the volume picking up and it is starting to get noticed finally. Best of luck to those of us that see the potential here rather than buying the flavour of the day like hyped AI stocks.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project